Tickerplace logo

Tickerplace

BioNexus Gene Lab Corp. logo

BGLCBioNexus Gene Lab Corp.

BGLC Stock Price, Valuation & Chart | BioNexus Gene Lab Corp.

Compare
$1.450-0.02 (-1.36%)

At close · 02 Sept 2026, 07:59 pm

Sector: HealthcareIndustry: Medical - Diagnostics & ResearchBGLC intrinsic valueBGLC calculated fair value vs price
OverviewFinancialsDividendsRatios

BGLC Historical price chart

BGLC Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization3.51M
PE Ratio-1.14
EPS-1.27
Trading Volume57.36
Today's High/Low1.45/1.38
Dividend Yield0.00
52 Week High/Low6.1/1.07
Shares Outstanding2.42M
BGLC Financial Statement
BGLC Analyst ratings
BGLC Analysis & performance metrics

BGLC Company profile

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam,…

BGLC Management team

Management
Too Kam ThamCEO
Managing Director
Kwan Wah Chan
Marketing Manager
Su-Leng TanCEO
Chief Executive Officer, President, Acting Chief Financial Officer, Secretary & Director
Total 3 executives

BGLC Frequently asked questions

What is BioNexus Gene Lab Corp. (BGLC) Stock Price?

Current stock price of BioNexus Gene Lab Corp. (BGLC) stock is $1.450. The stock price is -1.36% lower in the session. The intraday range can be seen from this page. Volume of BioNexus Gene Lab Corp. (BGLC) stock is 57.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the BioNexus Gene Lab Corp. (BGLC) stock price going up or down today?

The stock price of BioNexus Gene Lab Corp. (BGLC) can change with earnings, company news, and overall market sentiment. BioNexus Gene Lab Corp. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BioNexus Gene Lab Corp. stock expensive at its current price?

Whether BioNexus Gene Lab Corp. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BGLC on this page is -1.14. EPS on this page is -1.27. Compare those figures with peers and growth expectations before deciding if the current BioNexus Gene Lab Corp. price is justified.

How has the stock price of BioNexus Gene Lab Corp. (BGLC) performed historically?

Historical performance for BioNexus Gene Lab Corp. (BGLC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BGLC reacted to past earnings and market events.

Should I buy BioNexus Gene Lab Corp. (BGLC) stock, at this price?

Buying BioNexus Gene Lab Corp. (BGLC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.